The advent of a large number of new therapies for multiple sclerosis (MS) warrants the development of tools that enable selection of the best treatment option for each new patient with MS. Evidence ...

Multiple sclerosis (MS) is a chronic, often debilitating disease of the central nervous system (CNS) that affects between 400,000 and 570,000 persons in the United States, with an incidence among ...

WEST LAFAYETTE, Ind. — A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing. Researchers at Purdue University and the ...

Multiple sclerosis and lupus can have some overlapping symptoms, but they’re two distinct conditions. Read on to find out more about common symptoms and possible treatments. Multiple sclerosis (MS) ...

DUBLIN--(BUSINESS WIRE)--The "Primary Progressive Multiple Sclerosis (PPMS) - Disease and Drug Overview and Epidemiology" report has been added to Research and Markets' offering. The report provides ...

What is Multiple Sclerosis (MS)? Multiple sclerosis (MS) is a heterogeneous, immune-mediated disorder in which the body attacks its own myelin sheath that protects the nerve fibers of the central ...

"We were surprised that a higher proportion of life was associated with a higher risk of incident multiple sclerosis in immigrants because multiple sclerosis is often thought to be a predominant ...

DUBLIN--(BUSINESS WIRE)--The "Secondary Progressive Multiple Sclerosis (SPMS) - Disease Overview, Epidemiology and Drug Overview" report has been added to Research and Markets' offering. The report ...